Details for 2019880770

Up to date per 01.04.2026

Actions

Title / Product Name

EDARAVON-SUSPENSION ZUR ORALEN VERABREICHUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019880770

EP Publication Number

3875085

E-Number

1695472

Language

PCT Number

JP19043013

Publication Date

08.09.2021 A

19.06.2024 B1

Registration Date

19.06.2024

AT Publication Date

15.07.2024

Application Date

01.11.2019

Registration Number

Priorities

02.11.2018

2018207646

IPC

A61K 9/10 20060101AFI20230919BHEP

Maximum Duration of Protection

01.11.2039

Owner

Mitsubishi Tanabe Pharma Corporation3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka 541-8505JP

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

HAYAMA, Tetsuoc/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

TAKAHASHI, Tomohiroc/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

OMURA, Tomoyukic/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

HAYASHI, Koujic/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

MATSUDA, Munetomoc/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

MIYAZAWA, Tadashic/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

Information about Fees